Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CAR-T Cell Therapy for B-Cell Lymphoma
Recruiting1 awardPhase 1
Chapel Hill, North Carolina
This trial is testing a new cancer treatment that combines T cells and antibodies to create a more effective treatment than either alone. So far it has caused side effects including cytokine release syndrome and neurotoxicity, but the goal is to find a dose of the second study drug, AP1903, that reduces the severity of the cytokine release syndrome and/or neurotoxicity, but still allows the remaining iC9-CAR19 cells to effectively fight the lymphoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service